EMC Instytut Medyczny SA (EMC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EMC Instytut Medyczny SA (EMC) has a cash flow conversion efficiency ratio of 0.060x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł14.08 Million ≈ $3.88 Million USD) by net assets (zł236.46 Million ≈ $65.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EMC Instytut Medyczny SA (EMC) balance sheet quality index to measure how much of total assets are equity-financed.
EMC Instytut Medyczny SA - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how EMC Instytut Medyczny SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of EMC Instytut Medyczny SA to evaluate the quality of earnings relative to operating cash generation.
EMC Instytut Medyczny SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EMC Instytut Medyczny SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Unifiedpost Group SA
BR:UPG
|
0.008x |
|
HUHUTECH International Group Inc. Ordinary Shares
NASDAQ:HUHU
|
0.065x |
|
Daldrup & Söhne Aktiengesellschaft
F:4DS
|
0.051x |
|
Chosun Refractories Co Ltd
KO:000480
|
0.032x |
|
Cystech Electronics Corp
TWO:6651
|
0.066x |
|
ANDHRA PAPER LIMITED
NSE:ANDHRAPAP
|
0.033x |
|
Patriot National Bancorp Inc
NASDAQ:PNBK
|
-0.032x |
|
Kt Skylife
KO:053210
|
0.039x |
Annual Cash Flow Conversion Efficiency for EMC Instytut Medyczny SA (2007–2024)
The table below shows the annual cash flow conversion efficiency of EMC Instytut Medyczny SA from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see EMC Instytut Medyczny SA market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł232.55 Million ≈ $64.00 Million |
zł42.56 Million ≈ $11.71 Million |
0.183x | -23.06% |
| 2023-12-31 | zł211.71 Million ≈ $58.27 Million |
zł50.36 Million ≈ $13.86 Million |
0.238x | +8.19% |
| 2022-12-31 | zł190.72 Million ≈ $52.49 Million |
zł41.93 Million ≈ $11.54 Million |
0.220x | +121.47% |
| 2021-12-31 | zł190.28 Million ≈ $52.37 Million |
zł18.89 Million ≈ $5.20 Million |
0.099x | -17.22% |
| 2020-12-31 | zł186.32 Million ≈ $51.28 Million |
zł22.34 Million ≈ $6.15 Million |
0.120x | -37.45% |
| 2019-12-31 | zł116.17 Million ≈ $31.97 Million |
zł22.27 Million ≈ $6.13 Million |
0.192x | +511.17% |
| 2018-12-31 | zł113.17 Million ≈ $31.15 Million |
zł-5.28 Million ≈ $-1.45 Million |
-0.047x | -125.40% |
| 2017-12-31 | zł129.18 Million ≈ $35.55 Million |
zł23.71 Million ≈ $6.53 Million |
0.184x | +42.09% |
| 2016-12-31 | zł141.88 Million ≈ $39.05 Million |
zł18.33 Million ≈ $5.04 Million |
0.129x | +37.52% |
| 2015-12-31 | zł152.87 Million ≈ $42.07 Million |
zł14.36 Million ≈ $3.95 Million |
0.094x | +58.53% |
| 2014-12-31 | zł137.25 Million ≈ $37.77 Million |
zł8.13 Million ≈ $2.24 Million |
0.059x | -19.17% |
| 2013-12-31 | zł139.02 Million ≈ $38.26 Million |
zł10.19 Million ≈ $2.80 Million |
0.073x | -65.97% |
| 2012-12-31 | zł67.29 Million ≈ $18.52 Million |
zł14.49 Million ≈ $3.99 Million |
0.215x | -17.32% |
| 2011-12-31 | zł58.02 Million ≈ $15.97 Million |
zł15.12 Million ≈ $4.16 Million |
0.261x | +35992.91% |
| 2010-12-31 | zł62.00 Million ≈ $17.06 Million |
zł-45.00K ≈ $-12.38K |
-0.001x | -100.23% |
| 2009-12-31 | zł52.76 Million ≈ $14.52 Million |
zł16.58 Million ≈ $4.56 Million |
0.314x | +131.54% |
| 2008-12-31 | zł37.27 Million ≈ $10.26 Million |
zł5.06 Million ≈ $1.39 Million |
0.136x | +57.07% |
| 2007-12-31 | zł33.67 Million ≈ $9.27 Million |
zł2.91 Million ≈ $800.87K |
0.086x | -- |
About EMC Instytut Medyczny SA
EMC Instytut Medyczny SA owns hospitals and outpatient clinics in Poland. It operates in three segments: Hospital Care, Outpatient Care, and Clinical Trials. The company offers surgical procedures and diagnostics, carrying out medical procedures, specialist consultations, and performing minor procedures in non-hospital facilities, as well as testing new drugs and treatments. It also provides a ra… Read more